90 related articles for article (PubMed ID: 1811606)
1. [Experience with the use of immune intravenous immunoglobulin in symptomatic children with human immunodeficiency virus infection].
Jiménez E; Carrer MT; Pérez Dieppa I; Ortiz L; Fernández M
Bol Asoc Med P R; 1991 Dec; 83(12):538-42. PubMed ID: 1811606
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
Mofenson LM; Moye J
Pediatr Res; 1993 Jan; 33(1 Suppl):S80-7; discussion S87-9. PubMed ID: 8433880
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
5. Does intravenous immune globulin have a role in HIV-infected patients?
Yap PL
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection.
Kiehl MG; Stoll R; Broder M; Mueller C; Foerster EC; Domschke W
Arch Intern Med; 1996 Dec 9-23; 156(22):2545-50. PubMed ID: 8951297
[TBL] [Abstract][Full Text] [Related]
8. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
9. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
Stiehm ER; Fletcher CV; Mofenson LM; Palumbo PE; Kang M; Fenton T; Sapan CV; Meyer WA; Shearer WT; Hawkins E; Fowler MG; Bouquin P; Purdue L; Sloand EM; Nemo GJ; Wara D; Bryson YJ; Starr SE; Petru A; Burchett S
J Infect Dis; 2000 Feb; 181(2):548-54. PubMed ID: 10669338
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
[TBL] [Abstract][Full Text] [Related]
11. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM; Moye J; Korelitz J; Bethel J; Hirschhorn R; Nugent R
Pediatr Infect Dis J; 1994 Jun; 13(6):477-84. PubMed ID: 8078734
[TBL] [Abstract][Full Text] [Related]
12. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic human immunodeficiency virus infection in children in Puerto Rico. The University Pediatric Hospital experience.
Díaz C; Garcia-Castro JM; López-Correa R; Fernández Sein A; Martin de Pumarejo M; Colón JL; Beauchamp B; Flores L; Lugo L
Prog AIDS Pathol; 1992; 3(1):35-48. PubMed ID: 1606300
[No Abstract] [Full Text] [Related]
15. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM; Bethel J; Moye J; Flyer P; Nugent R
J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1103-13. PubMed ID: 8105072
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
[TBL] [Abstract][Full Text] [Related]
17. Home infusion of intravenous immune globulin in human immunodeficiency virus-infected children.
Poole JK
J Intraven Nurs; 1993; 16(1):18-22. PubMed ID: 8437042
[TBL] [Abstract][Full Text] [Related]
18. The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.
Huang LC; Myer L; Jaspan HB
BMC Infect Dis; 2008 Sep; 8():127. PubMed ID: 18811982
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients.
Crow ME
Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115
[TBL] [Abstract][Full Text] [Related]
20. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
